New Mountain Vantage Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$26.9M |
| 2 |
McKesson
MCK
|
+$23.6M |
| 3 |
Pfizer
PFE
|
+$20M |
| 4 |
Citizens Financial Group
CFG
|
+$15.5M |
| 5 |
CDW
CDW
|
+$12.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$35.8M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$24.6M |
| 3 |
Eagle Materials
EXP
|
+$22.8M |
| 4 |
Humana
HUM
|
+$22.1M |
| 5 |
UNT
UNIT Corporation
UNT
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.52% |
| 2 | Communication Services | 22.36% |
| 3 | Financials | 14.11% |
| 4 | Industrials | 7.89% |
| 5 | Energy | 3.8% |
Similar funds
New Mountain Vantage Advisers's Q1 2016 Portfolio in Review
As of Q1 2016, New Mountain Vantage Advisers held 44 positions worth $1.86B, down 14% from $2.15B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
New Mountain Vantage Advisers withdrew a net $214M in Q1 2016, closing 9 positions and reducing 20 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $24.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Communication Services and Financials.
Against the trend, New Mountain Vantage Advisers opened a new position in Pfizer worth $19.7M.
- New Mountain Vantage Advisers's largest Q1 2016 buy was Pfizer: 700,957 shares worth $19.7M.
- New Mountain Vantage Advisers added most to Shire pic in Q1 2016, an estimated $26.9M increase.
- New Mountain Vantage Advisers's biggest Q1 2016 reduction was Allergan plc, cutting an estimated $35.8M.
- New Mountain Vantage Advisers fully exited Thermo Fisher Scientific in Q1 2016, selling an estimated $24.6M.
- New Mountain Vantage Advisers's ten largest holdings make up 48% of its $1.86B portfolio in Q1 2016.
- New Mountain Vantage Advisers opened 3 new positions and closed 9 in Q1 2016.
- New Mountain Vantage Advisers's portfolio value fell 14% quarter-over-quarter to $1.86B.
Based on New Mountain Vantage Advisers's 13F filing for Q1 2016, filed 16 May 2016.